Improving health outcomes for adults with type 1 diabetes through integrated care
Evaluating the Integration of Mental Health Care Into the Treatment of Type 1 Diabetes
This study tests a new approach to diabetes care that includes support for mental health to see if it helps adults with type 1 diabetes feel better and manage their condition more effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Emory University Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Trial ID | NCT06448429 on ClinicalTrials.gov |
What this trial studies
This study evaluates an adapted collaborative care model aimed at enhancing health outcomes for adults diagnosed with type 1 diabetes (T1D). Over 18 months, participants will complete online surveys every six months regarding their psychosocial health and diabetes management. Those in the intervention group will consult with a behavioral health consultant to set personalized health goals and develop strategies for stress management and healthy behaviors. The study seeks to integrate behavioral health support into routine diabetes care to improve overall well-being.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with type 1 diabetes.
Not a fit: Patients with severe psychiatric illnesses or active suicidal ideation may not benefit from this study and will be referred to specialty care.
Why it matters
Potential benefit: If successful, this approach could lead to improved mental and physical health outcomes for patients with type 1 diabetes.
How similar studies have performed: Other studies have shown success in integrating behavioral health interventions with chronic disease management, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years) with T1D (based on clinical record diagnosis). Exclusion Criteria: * Patients who do not speak English or have reliable telephone access will be excluded. --- * Individuals with the presence of severe psychiatric illness (PHQ-9≥20) or active suicidal ideation will also be excluded and referred to specialty care.
Where this trial is running
Atlanta, Georgia
- Grady Health System — Atlanta, Georgia, United States (Recruiting)
Study contacts
- Principal investigator: Leslie Johnson, PhD, MPH — Emory University
- Study coordinator: Leslie Johnson, PhD, MPH
- Email: lmunoz@emory.edu
- Phone: 770-800-7085
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.